ant-005  (alomone labs)

Journal: FEBS Open Bio

Article Title: ProNGF processing in adult rat tissues and bioactivity of NGF prodomain peptides

doi: 10.1002/2211-5463.13768

Figure Lengend Snippet: (A–C) Dot blot and western blot for commercial antibody selectivity towards proNGF and/or NGF. (A) Detection of NGF, proNGF, C1 and C6 by using the different antibodies against NGF and proNGF: Abcam ab6199, Alomone ANT‐005 and Biosensis M‐1778‐B or S‐080. (B, C) The representative western blots show the ability and selectivity of (B) Abcam anti‐NGF antibody and (C) Biosensis (M‐1778‐B) anti‐proNGF antibody to detect recombinant NGF and/or proNGF.

Article Snippet: Similar results are obtained using another specific antibody against proNGF from Biosensis (S‐080) and Alomone (ANT‐005) data not showed.

Techniques: Dot Blot, Western Blot, Recombinant

Journal: FEBS Open Bio

Article Title: ProNGF processing in adult rat tissues and bioactivity of NGF prodomain peptides

doi: 10.1002/2211-5463.13768

Figure Lengend Snippet: Commercial antibodies for NGF and proNGF detection.

Article Snippet: ANT‐005 , Rabbit polyclonal to proNGF , ProNGF , P25427 , https://www.alomone.com/p/anti‐prongf‐2/ANT‐005.

Techniques:

Journal: FEBS Open Bio

Article Title: ProNGF processing in adult rat tissues and bioactivity of NGF prodomain peptides

doi: 10.1002/2211-5463.13768

Figure Lengend Snippet: Commercial antibodies for NGF and proNGF detection.

Article Snippet: Antibodies against proNGF (Alomone Labs, Jerusalem, Israel ANT‐005; 1 : 1000, and Biosensis, Thebarton, South Australia M‐1778‐B; 1 : 1000, S‐080; 1 : 1000), and NGF (Abcam, Cambridge, UK, ab6199, 1 : 1000) were preliminary used to evaluate their reactivity and selectivity to recognise NGF prodomain and/or its mature form by dot blot.

Techniques:

Journal: FEBS Open Bio

Article Title: ProNGF processing in adult rat tissues and bioactivity of NGF prodomain peptides

doi: 10.1002/2211-5463.13768

Figure Lengend Snippet: (A–C) Dot blot and western blot for commercial antibody selectivity towards proNGF and/or NGF. (A) Detection of NGF, proNGF, C1 and C6 by using the different antibodies against NGF and proNGF: Abcam ab6199, Alomone ANT‐005 and Biosensis M‐1778‐B or S‐080. (B, C) The representative western blots show the ability and selectivity of (B) Abcam anti‐NGF antibody and (C) Biosensis (M‐1778‐B) anti‐proNGF antibody to detect recombinant NGF and/or proNGF.

Article Snippet: Antibodies against proNGF (Alomone Labs, Jerusalem, Israel ANT‐005; 1 : 1000, and Biosensis, Thebarton, South Australia M‐1778‐B; 1 : 1000, S‐080; 1 : 1000), and NGF (Abcam, Cambridge, UK, ab6199, 1 : 1000) were preliminary used to evaluate their reactivity and selectivity to recognise NGF prodomain and/or its mature form by dot blot.

Techniques: Dot Blot, Western Blot, Recombinant

Journal: FEBS Open Bio

Article Title: ProNGF processing in adult rat tissues and bioactivity of NGF prodomain peptides

doi: 10.1002/2211-5463.13768

Figure Lengend Snippet: Expression of proNGF forms in different organs of adult male rats detected by Biosensis Antibody M‐1778‐B. Representative western blot of proNGF (Biosensis M‐1778‐B) detection in rat cortex, spinal cord and several peripheral tissues. “M” stands for protein marker.

Article Snippet: Antibodies against proNGF (Alomone Labs, Jerusalem, Israel ANT‐005; 1 : 1000, and Biosensis, Thebarton, South Australia M‐1778‐B; 1 : 1000, S‐080; 1 : 1000), and NGF (Abcam, Cambridge, UK, ab6199, 1 : 1000) were preliminary used to evaluate their reactivity and selectivity to recognise NGF prodomain and/or its mature form by dot blot.

Techniques: Expressing, Western Blot, Marker